Art

J-GLOBAL ID：201902243378006650   Reference number：19A2185573

Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study

mFOLFIRINOXで治療した進行膵臓癌患者における二次予防的PEG化G-CSFの臨床安全性と有効性:単一施設後向き研究

Author (16)： Yamao Kentaro (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Takenaka Mamoru (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Yoshikawa Tomoe (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Ishikawa Rei (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Okamoto Ayana (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Yamazaki Tomohiro (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Nakai Atsushi (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Omoto Shunsuke (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Kamata Ken (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Minaga Kosuke (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Hagiwara Satoru (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Sakurai Toshiharu (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Nishida Naoshi (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Chiba Yasutaka (Clinical Research Center, Kindai University Hospital, Japan) ,  Watanabe Tomohiro (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan) ,  Kudo Masatoshi (Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 58  Issue： 14  Page： 1993-2002(J-STAGE)  Publication year： 2019 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： mFOLFIRINOX療法 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2185573&from=J-GLOBAL&jstjournalNo=U0033A") }}

Author keywords (3)： pegylated G-CSF ,  mFOLFIRINOX ,  pancreatic cancer

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Substance index (3)： Fluorouracil ,  Irinotecan ,  Levoleucovorin

Reference (49)：

• 1. Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 41: 985-992, 2012.
• 2. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364: 1817-1825, 2011.
• 3. National Cancer Institute Common Terminology Criteria for Adverse Events v. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
• 4. Okusaka T, Ikeda M, Fukutomi A, et al. Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Sci 105: 1321-1326, 2014.
• 5. Chllamma MK, Cook N, Dhani NC, et al. FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience. Br J Cancer 115: 649-654, 2016.

Terms in the title (11)： 治療 ,  進行膵臓癌 ,  患者 ,  二次予防 ,  PEG化 ,  G-CSF ,  臨床 ,  安全性 ,  有効性 ,  施設 ,  研究